Published in Dis Mon on October 01, 2004
Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol (2008) 3.34
Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest (2009) 1.75
Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol (2012) 1.21
Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med (2011) 1.06
A meta-analysis of occupational trichloroethylene exposure and liver cancer. Int Arch Occup Environ Health (2007) 0.85
Risk Factors for the Development of Hepatocellular Carcinoma in Thailand. J Clin Transl Hepatol (2015) 0.78
'Obligate' anaerobic Salmonella strain YB1 suppresses liver tumor growth and metastasis in nude mice. Oncol Lett (2016) 0.75
Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med (2011) 6.31
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology (2008) 1.92
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial. Gastroenterology (2013) 1.63
Predictive value of stress myocardial perfusion imaging in liver transplant candidates. Am J Cardiol (2002) 0.94
Autoimmune hepatitis. Curr Treat Options Gastroenterol (2005) 0.88
Virological relapse in chronic hepatitis C. Antivir Ther (2009) 0.83
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial. Ann Intern Med (2015) 0.83
Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol (2007) 0.82
Pegylated IFN-α and ribavirin: emerging data in the treatment of special populations. Expert Rev Clin Pharmacol (2009) 0.80
Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown) (2011) 0.79
Fundal variceal bleeding after correction of portal hypertension in patients with cirrhosis. Gastrointest Endosc (2003) 0.77
Rates of recurrent variceal bleeding are low with modern esophageal banding strategies: a retrospective cohort study. Scand J Gastroenterol (2015) 0.75
Hepatitis C therapy: other players in the game. Clin Liver Dis (2011) 0.75